Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literature-Reference-Cited by-同舟云学术

Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literature

Published:2024-08-28 Issue: Volume: Page:1-11
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Cheng Connie¹,Dores Graça M.¹,Nayernama Afrouz¹,Jones S. Christopher¹,Rabik Cara A.²

Affiliation:

1. Division of Pharmacovigilance, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA

2. Division of Hematologic Malignancies, Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/08880018.2024.2395365

Reference42 articles.

1. Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase

2. The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia;Asselin BL.;Adv Exp Med Biol,1999

3. Asparlas. [package insert]. Boston MA: Servier Pharmaceuticals LLC. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761102s013lbl.pdf. Published November 29 2023. Accessed April 22 2024.

4. Oncaspar. [package insert]. Boston MA: Servier Pharmaceuticals LLC. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/103411s5207lbl.pdf. Published March 13 2024. Accessed April 22 2024.

5. Rylaze. [package insert]. Dublin Ireland: Jazz Pharmaceuticals Ireland Limited. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761179s007lbl.pdf. Published April 15 2024. Accessed April 22 2024.